Current Research Studies

A Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction with Busulfan, Cyclophosphamide and Fludarabine

FH9213

Phase: II
Clinicaltrials.gov ID: NCT02143830

What is the goal of the study?

Hematopoietic Stem Cell Transplantation for the Treatment of Patients with Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Risk-Adjusted Chemotherapy Only Cytoreduction with Busulfan, Cyclophosphamide and Fludarabine

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Kevin Baker
Study Team Member: Sheri Ballard, [email protected]